Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Neuro-Oncology
•
Medical Oncology
•
Neurology
What experience do you have with paralysis or myasthenia like symptoms developing on Temozolomide?
Related Questions
How do you approach treatment of sub-total resected ZFTA fusion ependymoma after radiation therapy in a young adult?
What is the expected timeframe for the development of radiation myelitis and therapies that have helped with neurologic symptoms?
How do you approach anti-seizure medication management when it was started by another team for a seizure-naive patient before/after craniotomy for a tumor?
What is your approach to management of a subtotally resected pineal parenchymal tumor of intermediate differentiation (CNS WHO grade 2)?
How well does a negative non-contrast MRI of the brain exclude metastasis in a patient with squamous cell carcinoma of the lung?
Are you offering Lutathera for multiple recurrent meningiomas?
What approach do you use when treating adult diffuse gliomas with H3-G34 mutations, now classified into their own category under the 2021 glioma guidelines?
Under what circumstances would you consider irradiation for brain metastases with active or recent bleeding?
For patients with primary CNS lymphoma and less than a CR to chemotherapy, in what situation would you consider partial or focal radiation?
For patients with metastatic cancer on a systemic therapy regimen that includes bevacizumab, are you comfortable treating brain metastases (SRS or WBRT) without holding bevacizumab?